The Clinical Research Center at RASF has been involved in a multitude of clinical trials over the past 40 years. The ongoing clinical research at RASF is helping the industry develop more effective treatments for autoimmune disease. RASF has been involved in trials that have led to the approval of many FDA approved medications that are currently used for treatment of Rheumatoid Arthritis, System Lupus Erythematosus, Psoriatic Arthritis, Fibromyalgia, Sjogren’s Syndrome, Osteoarthritis, Polymyalgia Rheumatica, Scleroderma, and many other conditions.
Our dedication to research keeps us at the forefront of clinical rheumatology, giving us access to cutting edge therapies that are generally not available to patients. In our clinical trials we adhere to good clinical practice guidelines, and these trials are carefully monitored by the FDA. Eligible participants are given full disclosure, enrollment is completely voluntary, and patients may discontinue their participation at any time. Upon being enrolled in a clinical trial, all of the participants rheumatological needs are closely monitored and managed by our Rheumatologists and Research Team.
To learn more about these cutting-edge treatments and your potential eligibility you can ask your doctor, or reach out to our dedicated research team. We are always available to answer questions regarding study details and eligibility requirements. Please feel free to call 561-361–6547, or email [email protected]. Heather and Michelle, our certified clinical Research Coordinators, will be happy to assist you.
Our dedication to research keeps us at the forefront of clinical rheumatology, giving us access to cutting edge therapies that are generally not available to patients. In our clinical trials we adhere to good clinical practice guidelines, and these trials are carefully monitored by the FDA. Eligible participants are given full disclosure, enrollment is completely voluntary, and patients may discontinue their participation at any time. Upon being enrolled in a clinical trial, all of the participants rheumatological needs are closely monitored and managed by our Rheumatologists and Research Team.
To learn more about these cutting-edge treatments and your potential eligibility you can ask your doctor, or reach out to our dedicated research team. We are always available to answer questions regarding study details and eligibility requirements. Please feel free to call 561-361–6547, or email [email protected]. Heather and Michelle, our certified clinical Research Coordinators, will be happy to assist you.